Dr Rifat Atun is Professor of Global Health Systems at Harvard University, where he is the Director of Global Health Systems Cluster at Harvard University's School of Public Health.
In 2006-13, Dr Atun was Professor of International Health Management and Head of the Health Management Group at Imperial College London. He is an Honorary Professor at the London School of Hygiene and Tropical Medicine. In 2008-12 he served as a member of the Executive Management Team of The Global Fund to Fight AIDS, Tuberculosis and Malaria as the Director of Strategy, Performance and Evaluation Cluster.
Rifat's research focuses on the design and implementation of health systems transformations and their impact on outcomes. His research also explores adoption and diffusion of innovations in health systems (e.g. health technologies, disease control programmes, and primary healthcare reforms), and innovative financing in global health. Organization. Rifat is a co-Investigator and the joint lead for the innovation work stream at the National Centre for Infection Prevention and Management at Imperial College. He is also a co-Investigator and the Theme Lead for 'Organisational Change, Sustainability and Evaluation' at Imperial College and Cambridge University Health Protection Research Unit for Antimicrobial Resistance and Healthcare Associated Infection. He has published widely in the Lancet, PLoS Medicine, Lancet Infectious Diseases, BMJ, AIDS, and Bulletin of the World Health Organization.
Rifat has worked with several governments globally and with the World Bank, World Health Organization, and the UK Department for International Development to design, implement and evaluate health system reform initiatives in more than 20 countries. He has led research and consultancy projects for GSK, Pfizer Inc., the Vodafone Group, Hofmann La Roche, PA Consulting, and Tata Consulting Services.
Rifat was the Founding Director of the MSc in International Health Management, BSc in Management and Medical Science, and Founding Co-Director of the Masters in Public Health Programme at Imperial College. He has been a director of Imperial College spin out companies operating in areas of health technology.
Rifat is a member of the MRC Global Health Group as the MRC Infections and Immunity Board representative. He serves as a member of the PEPFAR Scientific Advisory Board, the Norwegian Research Council's Global Health and Vaccination Research (GLOBVAC) Board, the Research Advisory Committee for the Public Health Foundation of India, and the US Institute of Medicine USAID Standing Committee on Strengthening Health Systems. In 2006-08 he served as a Member of the Advisory Committee for WHO Research Centre for Health Development in Japan. He was member of the Strategic Technical Advisory Group of the WHO for Tuberculosis and chaired the WHO Task Force on Health Systems and Tuberculosis Control. In 2009-12 he was the Chair of the STOP TB Partnership Coordinating Board.
Rifat is a Fellow of the Royal College of General Practitioners (UK), Fellow of the Faculty of Public Health of the Royal College of Physicians (UK), and a Fellow of the Royal College of Physicians (UK).
Education / Qualifications:
MBBS (Medical Diploma): Guy´s and St Thomas´ Hospitals, University of London
MBA: Executive MBA Programme, Management School, Imperial College London
- DIC: Diploma in Management, Imperial College London
- FRCGP : Fellow, Royal College of General Practitioners
- FFPH: Fellow,Faculty of Public Health of the Royal College of Physicians (UK)
- FRCP: Fellow, Royal College of Physicians (UK)
Borowitz, M, 2007, The unfinished journey from Semashko to Bismarck: Health reform in Central Asia from 1991 to 2006, Central Asian Survey, Vol:25, Pages:419-439
et al., 2007, Partnership and innovation in the life sciences, International Journal of Innovation Management, Vol:11, Pages:323-347
Car LT, Kyaw BM, Atun R, 2018, The role of eLearning in health management and leadership capacity building in health system: a systematic review, Human Resources for Health, Vol:16, ISSN:1478-4491
et al., 2018, Quantifying drivers of antibiotic resistance in humans: a systematic review., Lancet Infect Dis
et al., 2018, Transition to universal primary health care coverage in Brazil: Analysis of uptake and expansion patterns of Brazil's Family Health Strategy (1998-2012), Plos One, Vol:13, ISSN:1932-6203